menu

Chronic Heart Failure in Primary Care: Diagnosis, Treatment, Referral

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Chronic Heart Failure in Primary Care: Diagnosis, Treatment, Referral

Heart failure is becoming an increasing concern to healthcare worldwide. It is the only cardiovascular disorder that continues to increase in both ...

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Heart failure is becoming an increasing concern to healthcare worldwide. It is the only cardiovascular disorder that continues to increase in both prevalence and incidence, and as the population continues to age, it is expected that the prevalence of this disease will continue to rise. Most patients with heart failure will present themselves in general practice. Therefore, the community management of heart failure has become increasingly important and the role of primary care providers even more crucial. Improving the reliability of diagnosis in primary care is essential since determining the etiology and stage of heart failure leads to different management choices to improve symptoms, quality of life and disease prognosis. Furthermore, early diagnosis is needed when there may be no symptoms, since treatment can delay or reverse disease progression. A correct diagnosis is the cornerstone leading to effective management. Primary care physicians are in a pivotal position to make correct decisions regarding appropriate further investigation, treatment and referral.

    As a value added-resource, a specialized toolkit will also be included as a supplement to the webcast. The toolkit will provide for clinicians the latest treatment guidelines and updated reference guide. In addition, the toolkit will provide helpful information and resources for families and caregivers.

  • Learning Objectives

    • Recognize the risk factors for HF and the role of biomarkers in diagnosis and treatment;
    • Examine the importance of heart rate in cardiovascular risk of heart failure;
    • Apply the most recent clinical evidence for the management of chronic heart failure;
    • Incorporate effective techniques and educational tools to improve the patient’s knowledge and treatment of chronic heart failure.
  • Target Audience

    The intended audiences for this activity are physicians and other health care professionals who manage patients with chronic heart failure.

  • Disclosure of Conflicts of Interest

    Faculty: 
    James L. Januzzi, MD
    Hutter Family Professor of Medicine, Harvard Medical School; Roman W. DeSanctis Endowed Clinical Scholar, Massachusetts General Hospital, Boston, Massachusetts

    Moderator:
    John J. Russell, MD
    Abington Memorial Hospital
    Abington, Pennsylvania 

    Disclosure of Conflicts of Interest:

    According to the disclosure policy of the University of Cincinnati College of Medicine, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with the commercial companies related to this activity.  All relevant relationships that are identified are reviewed for potential conflicts of interest. If a conflict of interest is identified, it is the responsibility of the University of Cincinnati College of Medicine to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

    The following faculty has reported real or apparent conflicts of interest that have been resolved:

    James L. Januzzi, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen, Inc.; Critical Diagnostics; Novartis Pharmaceuticals Corporation; Roche.
    Received grants for clinical research from: Siemens AG; Roche; Thermo Fisher Scientific Inc.

    John J. Russell, MD (host) has disclosed the following relevant financial relationships:
    Employed by ReachMD.

    The following reviewers/planners/authors have reported real or apparent conflicts of interest:

    • Susan Tyler, MEd, CMP, CHCP, CME Director, has nothing to disclose.
    • Rick E. Ricer, MD, Professor Emeritus, has nothing to disclose.
    • Deborah Cole, BS, Program Coordinator, has nothing to disclose.
    • Otto Ratz, MD, has nothing to disclose.
    • Christina Culbert, MSc, has nothing to disclose.
  • Accreditation and Credit Designation Statements

    This CME activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and CORE Medical Education, LLC. University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation

    The University of Cincinnati designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    This CME activity was developed through the joint providership of the University of Cincinnati and CORE Medical Education, LLC.

  • Commercial Support

    This CME activity is supported by an educational grant from Novartis Pharmaceuticals.

    Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati College of Medicine nor CORE Medical Education, LLC, recommends the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati College of Medicine or CORE Medical Education, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Instruction for Participation

    There are no fees for participating in and receiving CME credit for this online activity. During the period of July 17, 2017 to July 16, 2018, participants must 1) read the CME information, including the learning objectives and faculty disclosures; 2) listen to the full content of the activity and reflect upon its teachings; 3) successfully complete the post-test with a passing score of 70% and the evaluation at the end of the activity.

    Participants who successfully complete the activity, post test and evaluation will have a statement of credit made available immediately.

  • Contact Information

    Accreditation Support:
    Please contact the University of Cincinnati Continuing Medical Education Department at uccme@uc.edu or call 513-558-7277.

    Technical Support:
    For any technical issues or issues with your CME Certificate, please contact ReachMD at info@reachmd.com or call (866) 423-7849.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.